The alternative text for this image may have been generated using AI. The eye-care company Alcon Research has entered into licensing and purchase option agreements with Potentia Pharmaceuticals to ...
Target Levels of Active Drug Achieved in Healthy Volunteers with Oral Twice-Daily Dosing; Supportive Impact on Pharmacodynamic Biomarker of Complement Activity ANX1502 Generally Well Tolerated Across ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results